Inventor
PETERSEN JOHN S
US51 patents
⚠️ This page may combine multiple inventors who share the name “PETERSEN JOHN S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNDEVRX INC
14 patentsUS9730955B2Aug 15, 2017
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
SYNDEVRX INC10 citations93
US10010544B2Jul 3, 2018
METAP2 inhibitors and methods of treating obesity
SYNDEVRX INC11 citations92
US9757373B2Sep 12, 2017
MetAP2 inhibitors and methods of treating obesity
SYNDEVRX INC13 citations92
US9750737B2Sep 5, 2017
METAP2 inhibitors and methods of treating obesity
SYNDEVRX INC11 citations92
US9433600B2Sep 6, 2016
METAP2 inhibitors and methods of treating obesity
SYNDEVRX INC15 citations92
US9173956B2Nov 3, 2015
METAP2 inhibitors and methods of treating obesity
SYNDEVRX INC22 citations92
US10159692B2Dec 25, 2018
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
SYNDEVRX INC8 citations84
US9969722B2May 15, 2018
Fumagillol derivatives and polymorphs thereof
SYNDEVRX INC7 citations84
US9585909B2Mar 7, 2017
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
SYNDEVRX INC10 citations84
US11304944B2Apr 19, 2022
MetAP2 inhibitors and methods of treating obesity
SYNDEVRX INC3 citations83
US10588904B2Mar 17, 2020
METAP2 inhibitors and methods of treating obesity
SYNDEVRX INC4 citations83
US10287277B2May 14, 2019
Fumagillol derivatives and polymorphs thereof
SYNDEVRX INC4 citations73
US9895449B2Feb 20, 2018
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
SYNDEVRX INC4 citations73
US10722532B2Jul 28, 2020
Polymer-conjugated METAP2 inhibitors, and therapeutic methods of use thereof
SYNDEVRX INC0 citations52
GELTEX PHARMA INC
11 patentsUS5929184AJul 27, 1999
Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
GELTEX PHARMA INC96 citations98
US6294163B1Sep 25, 2001
Polymers containing guanidinium groups as bile acid sequestrants
GELTEX PHARMA INC87 citations97
US6248318B1Jun 19, 2001
Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
GELTEX PHARMA INC30 citations96
US6203785B1Mar 20, 2001
Poly(diallylamine)-based bile acid sequestrants
GELTEX PHARMA INC54 citations96
US6083497AJul 4, 2000
Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
GELTEX PHARMA INC48 citations96
US5900475AMay 4, 1999
Hydrophobic sequestrant for cholesterol depletion
GELTEX PHARMA INC56 citations96
US5969090AOct 19, 1999
Hydrophobic sequestrant for cholesterol depletion
GELTEX PHARMA INC33 citations93
US6365186B1Apr 2, 2002
Combination therapy for treating hypercholesterolemia
GELTEX PHARMA INC17 citations92
US6264938B1Jul 24, 2001
Combination therapy for treating hypercholestrolemia
GELTEX PHARMA INC18 citations92
US6187762B1Feb 13, 2001
Polyvalent polymers for the treatment of rotavirus infection
GELTEX PHARMA INC20 citations92
US5891862AApr 6, 1999
Polyvalent polymers for the treatment of rotavirus infection
GELTEX PHARMA INC20 citations92
GENZYME CORP
8 patentsUS6733780B1May 11, 2004
Direct compression polymer tablet core
GENZYME CORP122 citations97
US7638524B2Dec 29, 2009
Combination therapy for treating hypercholesterolemia
GENZYME CORP12 citations92
US7125547B2Oct 24, 2006
Poly(diallylamine)-based bile acid sequestrants
GENZYME CORP8 citations74
US6610283B1Aug 26, 2003
Poly(diallylamine)-based bile acid sequestrants
GENZYME CORP4 citations74
US9931358B2Apr 3, 2018
Direct compression polymer tablet core
GENZYME CORP2 citations71
US9579343B2Feb 28, 2017
Direct compression polymer tablet core
GENZYME CORP2 citations71
US8377428B2Feb 19, 2013
Low salt forms of polyallylamine
GENZYME CORP4 citations62
US7541024B2Jun 2, 2009
Low salt forms of polyallylamine
GENZYME CORP4 citations62
ASML MASKTOOLS BV
3 patentsUS6541167B2Apr 1, 2003
Optical proximity correction
ASML MASKTOOLS BV75 citations98
US6335130B1Jan 1, 2002
System and method of providing optical proximity correction for features using phase-shifted halftone transparent/semi-transparent features
ASML MASKTOOLS BV65 citations96
USRE40084EFeb 19, 2008
Optical proximity correction
ASML MASKTOOLS BV6 citations74
MARKLE DAVID A
3 patentsUS9304410B2Apr 5, 2016
Apparatus and method of direct writing with photons beyond the diffraction limit
MARKLE DAVID A2 citations61
US8642232B2Feb 4, 2014
Method of direct writing with photons beyond the diffraction limit
MARKLE DAVID A2 citations61
US9195139B2Nov 24, 2015
Apparatus and method of direct writing with photons beyond the diffraction limit using two-color resist
MARKLE DAVID A0 citations51
MILLIPORE CORP
2 patentsPETERSEN JOHN S
2 patentsASM LITHOGRAPHY BV
1 patentWATERS INVESTMENTS LTD
1 patentSHIPLEY CO LLC
1 patentROCHESTER INST TECH
1 patentPERIODIC STRUCTURES INC
1 patentPETERSEN ADVANCED LITHOGRAPHY
1 patentTYLER JOSEPH
1 patentShowing the top 50 of 51 patents by PatentIndex Score.